Cargando…

Sputnik V protection from COVID-19 in people living with HIV under antiretroviral therapy

BACKGROUND: HIV-infection is known to aggravate the course of many infectious diseases, including COVID-19. International guidance recommends vaccination of HIV+ individuals against SARS-CoV-2. There is a paucity of data on epidemiological efficacy assessment of COVID-19 vaccines among HIV+. This pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gushchin, Vladimir A., Tsyganova, Elena V., Ogarkova, Darya A., Adgamov, Ruslan R., Shcheblyakov, Dmitry V., Glukhoedova, Nataliia V., Zhilenkova, Aleksandra S., Kolotii, Alexey G., Zaitsev, Roman D., Logunov, Denis Y., Gintsburg, Alexander L., Mazus, Alexey I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943473/ https://www.ncbi.nlm.nih.gov/pubmed/35340627 http://dx.doi.org/10.1016/j.eclinm.2022.101360

Ejemplares similares

Current Trends of HIV Infection in the Russian Federation
por: Ogarkova, Daria, et al.
Publicado: (2023)

Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance
por: Sukhikh, Gennady T., et al.
Publicado: (2022)

Revaccination in Age-Risk Groups with Sputnik V Is Immunologically Effective and Depends on the Initial Neutralizing SARS-CoV-2 IgG Antibodies Level
por: Godkov, Mikhail A., et al.
Publicado: (2022)

Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply
por: Logunov, Denis Y, et al.
Publicado: (2021)

Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance
por: Shkoda, Andrey S., et al.
Publicado: (2022)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
por: Lapa, Daniele, et al.
Publicado: (2022)

An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults
por: Tukhvatulin, Amir I., et al.
Publicado: (2021)

Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants
por: Gushchin, Vladimir A., et al.
Publicado: (2021)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
por: Tukhvatulin, Amir I., et al.
Publicado: (2022)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
por: Logunov, Denis Y, et al.
Publicado: (2020)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

A Case of Moderately Severe COVID-19 in a Healthcare Worker in Russia: Virus Isolation and Full Genome Sequencing
por: Shchetinin, Alexey M, et al.
Publicado: (2021)

Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses
por: Tukhvatulin, Amir I., et al.
Publicado: (2016)

Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis
por: Burmistrova, Daria A., et al.
Publicado: (2016)

Stimulation of Dectin-1 and Dectin-2 during Parenteral Immunization, but Not Mincle, Induces Secretory IgA in Intestinal Mucosa
por: Dzharullaeva, Alina S., et al.
Publicado: (2018)

rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
por: Derkaev, Artem A., et al.
Publicado: (2022)

Sputnik, mi amor /
por: Murakami, Haruki, 1949-
Publicado: (2009)

Sputnik, mi amor/
por: Murakami, Haruki 1949-
Publicado: (2012)

Sputnik, mi amor /
por: Murakami, Haruki, 1949-

The arrival of Sputnik V
por: Balakrishnan, Vijay Shankar
Publicado: (2020)

Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice
por: Godakova, Svetlana A., et al.
Publicado: (2019)

Antigenic Cartography Indicates That the Omicron BA.1 and BA.4/BA.5 Variants Remain Antigenically Distant to Ancestral SARS-CoV-2 after Sputnik V Vaccination Followed by Homologous (Sputnik V) or Heterologous (Comirnaty) Revaccination
por: Astakhova, Ekaterina A., et al.
Publicado: (2023)

Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection
por: Voronina, Daria V., et al.
Publicado: (2022)

SARS-CoV-2-specific T Cell Immunity after Vaccination with Sputnik V and BBIBP-CorV
por: Babrukevich, Darya, et al.
Publicado: (2022)

Hemolytic Performance in Two Generations of the Sputnik Left Ventricular Assist Device: A Combined Numerical and Experimental Study
por: Romanova, Alexandra N., et al.
Publicado: (2022)

NOD1/2 and the C-Type Lectin Receptors Dectin-1 and Mincle Synergistically Enhance Proinflammatory Reactions Both In Vitro and In Vivo
por: Tukhvatulin, Amir I, et al.
Publicado: (2020)

Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis
por: Gushchin, Vladimir A., et al.
Publicado: (2022)

Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice
por: Tukhvatulin, Amir, et al.
Publicado: (2020)

Sputnik V vaccine goes global
por: Lawton, Graham
Publicado: (2021)

Controversy surrounding the Sputnik V vaccine
por: Cazzola, Mario, et al.
Publicado: (2021)

Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia
por: Komissarov, Alexey A., et al.
Publicado: (2022)

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts
por: Tutykhina, Irina, et al.
Publicado: (2018)

Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
por: Fomina, Daria S., et al.
Publicado: (2023)

Phenotypic Changes in T and NK Cells Induced by Sputnik V Vaccination
por: Boyko, Anna A., et al.
Publicado: (2023)

Far East Scarlet-Like Fever Caused by a Few Related Genotypes of Yersinia pseudotuberculosis, Russia
por: Timchenko, Nelly F., et al.
Publicado: (2016)

Functional Characteristics of Serum Anti-SARS-CoV-2 Antibodies against Delta and Omicron Variants after Vaccination with Sputnik V
por: Radion, Elizaveta I., et al.
Publicado: (2023)

Antibody durability at 1 year after Sputnik V vaccination
por: Sanchez, Lautaro, et al.
Publicado: (2022)

Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023)

La historia de Sputnik y David /
por: Carballido, Emilio
Publicado: (1995)

Astrophysics in a nutshell from the telescope to the sputnik
por: Alfvén, Hannes, et al.
Publicado: (1988)

Cannot write session to /tmp/vufind_sessions/sess_drsvpkda7ngcpn1mle7md7p1dv